| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01377376 Details | 2016-12-07 Interventional | 3 | - | Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Non-small-cell … | - - | |||
| NCT00752986 2008-000579-12 Details | 2016-12-05 Interventional | 2 | 39 | Fulvestrant Breast Neoplasm… Breast Cancer | - - | |||
| NCT01746602 Details | 2016-12-02 Interventional | 3 | 38 | Timolol Glaucoma Healthy | - - | |||
| NCT01457001 Details | 2016-12-01 Interventional | 3 | 284 | Vitamin D Kidney Failure,… Chronic Renal F… | - - | |||
| NCT00069329 Details | 2016-12-01 Interventional | 1/2 | 43 | Interleukin 1 R… Arthropathy, Ne… Cryopyrin-Assoc… Joint Diseases Nervous System … Papilledema Urticaria | data submitted for Food and Drug Administration (FDA) approval Data reported is on 26 patients who completed their 3 year assessment and 20 of these patients also completed their 5 year assessment. | |||
| NCT00040391 Details | 2016-12-01 Interventional | 2 | - | Fluorouracil Irinotecan Leucovorin Colorectal Neop… Diarrhea | - - | |||
| NCT02434523 Details | 2016-11-30 Interventional | 2/3 | 30 | Amitriptyline Laryngeal Disea… Laryngitis Chronic Larynge… | concern regarding study design Early termination leading to small numbers of subjects analyzed | |||
| NCT00699842 Details | 2016-11-29 Interventional | 1/2 | 8 | Lenalidomide Myelodysplastic… Preleukemia Syndrome Low to Intermed… MDS Myelodysplastic… Non-deletion 5q | Administratively terminated per FDA recommendation Study was terminated as the objectives of this study have already been addressed in a larger study, and therefore the study is unlikely to yield any new information. The study closed before any data for the outcome measures was able to be collected. | |||
| NCT00359671 Details | 2016-11-29 Interventional | 1 | - | Docetaxel Neoplasms Advanced Solid … | - - | |||
| NCT01450696 2011-001526-19 Details | 2016-11-28 Interventional | 3 | 296 | Capecitabine Trastuzumab Stomach Neoplas… Gastric Cancer | futility following planned interim analysis Trial was stopped for futility based on pre-planned interim analysis results. | |||
| NCT02963103 Details | 2016-11-23 Interventional | 4 | 13 | Tacrolimus Kidney Transpla… | Sponsor decision to terminate the study because subject enrollment was difficult. - | |||
| NCT02618499 Details | 2016-11-23 Interventional | 3 | 180 | Oxytocin Placental Trans… | Futility suggested by DSMC - | |||
| NCT01561950 Details | 2016-11-23 Interventional | 1 | 91 | Clopidogrel Hemorrhage Haemostasis Healthy | - - | |||
| NCT02599077 Details | 2016-11-22 Interventional | 2/3 | [1 Refs] | - | Dienogest Levonorgestrel Endometriosis | - - | ||
| NCT00912444 Details | 2016-11-22 Interventional | 3 | 102 | Cyclophosphamid… Docetaxel Doxorubicin Epirubicin Breast Neoplasm… Breast Cancer | TAC treatment was associated with better survial outcome compared with TC treatment, we
terminated recruiting and waiting for longer follow up period. - | |||
| NCT01886573 Details | 2016-11-18 Interventional | 1 | - | Azacitidine Entinostat Histone Deacety… Carcinoma Carcinoma, Non-… Lung Neoplasms Stage IA Non-Sm… Stage IB Non-Sm… Stage IIA Non-S… Stage IIB Non-S… Stage IIIA Non-… | - - | |||
| NCT01329250 Details | 2016-11-18 Interventional | 4 | 9 | Moxifloxacin Tuberculosis | slow enrolment of patients and new insights - | |||
| NCT00316212 Details | 2016-11-18 Interventional | 2 | - | INS 50589 Coronary Diseas… | - - | |||
| NCT01950195 Details | 2016-11-15 Interventional | 1 | 4 | Ipilimumab Melanoma Neoplasm Metast… Newly Diagnosed… | Local IRB required us to submit amendment as a separate study. - | |||
| NCT00557219 Details | 2016-11-15 Interventional | 3 | 60 | Fenoldopam Ketanserin Acute Kidney In… Renal Insuffici… Acute Renal Fai… | Main cooperator finished cooperation - |